Latest Insider Transactions at Liquidia Corp (LQDA)
This section provides a real-time view of insider transactions for Liquidia Corp (LQDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Liquidia Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Liquidia Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 06
2023
|
Jason Adair Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+29.87%
|
-
|
|
May 31
2023
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.62%
|
-
|
|
May 31
2023
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
651
-0.63%
|
$5,208
$8.08 P/Share
|
|
May 31
2023
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+1.79%
|
-
|
|
May 31
2023
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+1.31%
|
-
|
|
May 31
2023
|
Robert A Lippe Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
597
-0.31%
|
$4,776
$8.08 P/Share
|
|
May 31
2023
|
Robert A Lippe Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,719
+0.9%
|
-
|
|
Feb 28
2023
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+2.45%
|
-
|
|
Feb 28
2023
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,171
-2.1%
|
$15,197
$7.56 P/Share
|
|
Feb 28
2023
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+6.78%
|
-
|
|
Feb 28
2023
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+5.11%
|
-
|
|
Feb 28
2023
|
Robert A Lippe Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
2,033
-1.07%
|
$14,231
$7.56 P/Share
|
|
Feb 28
2023
|
Robert A Lippe Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+3.48%
|
-
|
|
Jan 11
2023
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
104,167
+22.36%
|
-
|
|
Jan 11
2023
|
Scott Moomaw Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+47.22%
|
-
|
|
Jan 11
2023
|
Roger Jeffs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
289,500
+36.82%
|
-
|
|
Jan 11
2023
|
Michael Kaseta CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
124,667
+43.41%
|
-
|
|
Jan 11
2023
|
Rajeev Saggar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+31.99%
|
-
|
|
Jan 11
2023
|
Robert A Lippe Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+31.48%
|
-
|
|
Jan 03
2023
|
Roger Jeffs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,807
+7.09%
|
-
|
|
Oct 03
2022
|
Roger Jeffs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,423
+18.62%
|
-
|
|
Sep 13
2022
|
Michael Kaseta CFO and COO |
BUY
Open market or private purchase
|
Direct |
8,000
+17.44%
|
$40,000
$5.99 P/Share
|
|
Sep 06
2022
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,600
+5.66%
|
$163,000
$5.65 P/Share
|
|
Sep 06
2022
|
Roger Jeffs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
43,820
+21.52%
|
$219,100
$5.57 P/Share
|
|
Sep 06
2022
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+2.29%
|
$1,250,000
$5.62 P/Share
|
|
Aug 31
2022
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,166
+0.95%
|
$8,664
$4.9 P/Share
|
|
Aug 31
2022
|
Scott Moomaw Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
2,160
+18.05%
|
$8,640
$4.9 P/Share
|
|
Aug 31
2022
|
Robert A Lippe Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
1,918
+1.92%
|
$7,672
$4.9 P/Share
|
|
Aug 31
2022
|
Michael Kaseta CFO and COO |
BUY
Open market or private purchase
|
Direct |
1,927
+6.06%
|
$7,708
$4.9 P/Share
|
|
Aug 31
2022
|
Roger Jeffs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
993
+0.85%
|
$3,972
$4.9 P/Share
|
|
Jul 18
2022
|
Rajeev Saggar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,834
+50.0%
|
-
|
|
May 31
2022
|
Michael Kaseta CFO and COO |
BUY
Open market or private purchase
|
Direct |
18,700
+26.33%
|
$74,800
$4.01 P/Share
|
|
May 25
2022
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
79,400
+0.76%
|
$238,200
$3.4 P/Share
|
|
May 24
2022
|
Roger Jeffs Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
28,000
+37.54%
|
$84,000
$3.53 P/Share
|
|
May 24
2022
|
Robert A Lippe Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
29,628
+24.62%
|
$88,884
$3.38 P/Share
|
|
May 19
2022
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
85,000
+0.82%
|
$425,000
$5.81 P/Share
|
|
May 18
2022
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
76,404
+0.74%
|
$382,020
$5.89 P/Share
|
|
May 17
2022
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
59,700
+0.58%
|
$298,500
$5.99 P/Share
|
|
Apr 18
2022
|
Paul B Manning Director |
BUY
Open market or private purchase
|
Direct |
392,156
+50.0%
|
$1,960,780
$5.1 P/Share
|
|
Apr 18
2022
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
1,764,705
+14.88%
|
$8,823,525
$5.1 P/Share
|
|
Mar 31
2022
|
Roger Jeffs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
154,167
+9.09%
|
-
|
|
Mar 31
2022
|
Damian De Goa Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,625
+8.84%
|
-
|
|
Mar 31
2022
|
Paul B Manning Director |
BUY
Grant, award, or other acquisition
|
Indirect |
435,674
+50.0%
|
-
|
|
Mar 31
2022
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,158
+0.96%
|
-
|
|
Nov 12
2021
|
Robert A Lippe Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,130
-8.31%
|
$52,520
$4.97 P/Share
|
|
Nov 12
2021
|
Tushar Shah CMO and Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
12,369
-12.18%
|
$49,476
$4.97 P/Share
|
|
Nov 10
2021
|
Arthur S Kirsch Director |
BUY
Open market or private purchase
|
Direct |
30,000
+48.39%
|
$120,000
$4.24 P/Share
|
|
Nov 10
2021
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,250
+50.0%
|
-
|
|
Nov 10
2021
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,650
+50.0%
|
-
|
|
Nov 10
2021
|
Robert A Lippe Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,250
+39.16%
|
-
|